correction to lancet infect dis 2019; published online april 20. https://doi.org/10.1016/s1473-3099(20)30160-2 (the lancet infectious diseases (2020) 20(7) (816‚Äì826), (s1473309920301602), (10.1016/s1473-3099(20)30160-2). ¬© 2020 Elsevier LtdFolegatti PM, Bittaye M, Flaxman A, et al. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect Dis 2020; published online April 20. https://doi. org/10.1016/S1473-3099(20)30160-2‚ÄîIn this Article the spelling of Julia Marshall's name was incorrect. This correction has been made to the online version as of June 8, 2020, and will be made to the printed version.